74 related articles for article (PubMed ID: 28365934)
21. Effect of Fee on Cervical Cancer Screening Attendance--ScreenFee, a Swedish Population-Based Randomised Trial.
Alfonzo E; Andersson Ellström A; Nemes S; Strander B
PLoS One; 2016; 11(3):e0150888. PubMed ID: 26986848
[TBL] [Abstract][Full Text] [Related]
22. Young Singaporean women's knowledge of cervical cancer and pap smear screening: a descriptive study.
Shea J; Klainin-Yobas P; Mackey S
J Clin Nurs; 2013 Dec; 22(23-24):3310-9. PubMed ID: 24580785
[TBL] [Abstract][Full Text] [Related]
23. The evaluation of cervical cancer screening by combining speculoscopy with Papanicolaou smear examination in Taiwan.
Chang JI; Ou CH; Wu KM; Chen CC; Cheng KC
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):430-4. PubMed ID: 12433029
[TBL] [Abstract][Full Text] [Related]
24. Pap test use and cervical cancer incidence in First Nations women living in Manitoba.
Decker KM; Demers AA; Kliewer EV; Biswanger N; Musto G; Elias B; Griffith J; Turner D
Cancer Prev Res (Phila); 2015 Jan; 8(1):49-55. PubMed ID: 25403849
[TBL] [Abstract][Full Text] [Related]
25. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C
Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
[TBL] [Abstract][Full Text] [Related]
26. Knowledge, attitudes and practices about the Pap smear among medical workers in Naresuan University Hospital, Thailand.
Oranratanaphan S; Amatyakul P; Iramaneerat K; Srithipayawan S
Asian Pac J Cancer Prev; 2010; 11(6):1727-30. PubMed ID: 21338223
[TBL] [Abstract][Full Text] [Related]
27. [Women's social conditions and their participation in Cervical Cancer Population Screening Program in Poland].
Spaczyński M; Nowak-Markwitz E; Januszek-Michalecka L; Karowicz-Bilińska A
Ginekol Pol; 2009 Nov; 80(11):833-8. PubMed ID: 20088397
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer screening among women ≥70 years of age in the United States-A referral problem or patient choice.
Guo F; Hirth JM; Berenson AB
Prev Med; 2015 Dec; 81():427-32. PubMed ID: 26500084
[TBL] [Abstract][Full Text] [Related]
29. Randomized Intervention of Self-Collected Sampling for Human Papillomavirus Testing in Under-Screened Rural Women: Uptake of Screening and Acceptability.
Racey CS; Gesink DC; Burchell AN; Trivers S; Wong T; Rebbapragada A
J Womens Health (Larchmt); 2016 May; 25(5):489-97. PubMed ID: 26598955
[TBL] [Abstract][Full Text] [Related]
30. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
31. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
32. Excessive Pap smears due to opportunistic cervical cancer screening.
Freitas RA; Carvasan GA; Morais SS; Zeferino LC
Eur J Gynaecol Oncol; 2008; 29(5):479-82. PubMed ID: 19051817
[TBL] [Abstract][Full Text] [Related]
33. A quasi-randomized trial on the effectiveness of an invitation letter to improve participation in a setting of opportunistic screening for cervical cancer.
de Jonge E; Cloes E; Op de Beeck L; Adriaens B; Lousbergh D; Orye GG; Buntinx F
Eur J Cancer Prev; 2008 Jun; 17(3):238-42. PubMed ID: 18414195
[TBL] [Abstract][Full Text] [Related]
34. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
Soccio J; Brown M; Comino E; Friesen E
J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
[TBL] [Abstract][Full Text] [Related]
35. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Impact of Human Papillomavirus DNA Self-sampling on the Uptake of Cervical Cancer Screening.
Wong EL; Chan PK; Chor JS; Cheung AW; Huang F; Wong SY
Cancer Nurs; 2016; 39(1):E1-E11. PubMed ID: 25730587
[TBL] [Abstract][Full Text] [Related]
37. A primary healthcare-based intervention to improve a Danish cervical cancer screening programme: a cluster randomised controlled trial.
Jensen H; Svanholm H; Støvring H; Bro F
J Epidemiol Community Health; 2009 Jul; 63(7):510-5. PubMed ID: 19228681
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the nationwide cervical screening programme in Thailand: a case-control study.
Kasinpila C; Promthet S; Vatanasapt P; Sasieni P; Parkin DM
J Med Screen; 2011; 18(3):147-53. PubMed ID: 22045824
[TBL] [Abstract][Full Text] [Related]
39. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience.
Sepúlveda C; Prado R
Cancer Detect Prev; 2005; 29(5):405-11. PubMed ID: 16188399
[TBL] [Abstract][Full Text] [Related]
40. Trend in cervical cancer screening in Spain (2003-2009) and predictors of adherence.
Martín-López R; Hernández-Barrera V; de Andres AL; Carrasco-Garrido P; de Miguel AG; Jimenez-Garcia R
Eur J Cancer Prev; 2012 Jan; 21(1):82-8. PubMed ID: 22129658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
